pneumococcus conjugate vaccine
ApprovedCompleted 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Vaccines, Pneumococcal Conjugate Vaccine
Conditions
Vaccines, Pneumococcal Conjugate Vaccine
Trial Timeline
Nov 1, 2002 → Sep 1, 2007
NCT ID
NCT00581620About pneumococcus conjugate vaccine
pneumococcus conjugate vaccine is a approved stage product being developed by Pfizer for Vaccines, Pneumococcal Conjugate Vaccine. The current trial status is completed. This product is registered under clinical trial identifier NCT00581620. Target conditions include Vaccines, Pneumococcal Conjugate Vaccine.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00581620 | Approved | Completed |
Competing Products
20 competing products in Vaccines, Pneumococcal Conjugate Vaccine